《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2014年 > 9期

利拉鲁肽经激活糖尿病大鼠肾脏内皮源性一氧化氮合酶活性降低尿白蛋白排泄的研究

来自:中国糖尿病杂志  编辑:白莲 李春君 邢云芝 于倩 刘晓娟 于珮|点击数:|2014-09-24

  糖尿病基础研究

  【摘要】 目的 探讨利拉鲁肽对糖尿病大鼠24 hUAlb排泄的影响及可能机制。 方法 将30只大鼠分为正常对照(NC)组、糖尿病(DM)组和利拉鲁肽(DM+L)组。各组给药前后检测血肌酐(Scr)、BUN和24 hUAlb。HE染色和PAS染色观察肾脏形态学改变;Western blot检测肾脏GLP-1受体(GLP-1R)、内皮源性一氧化氮合酶(eNOS)、p-eNOS表达;ELISA检测eNOS活性。 结果 与NC组相比,DM组Scr、BUN、24 hUAlb升高(P<0.05或P<0.01),肾脏eNOS表达量比较差异无统计学意义,GLP-1R、p-eNOS表达及eNOS活性降低(P<0.05或P<0.01)。与DM组相比,DM+L组Scr、BUN、24 hUAlb降低(P<0.05或P<0.01),肾脏GLP-1R、p-eNOS表达及eNOS活性升高(P<0.05或P<0.01)。 结论 利拉鲁肽可经上调糖尿病大鼠肾脏GLP-1R表达,提高肾小球血管内皮细胞eNOS活性,减少糖尿病大鼠UAlb排泄。

  【关键词】利拉鲁肽;糖尿病肾病;GLP-1受体;内皮源性一氧化氮合酶;尿白蛋白排泄

  【Abstract】Objective To explore the effects of liraglutide on 24 hUAlb excretion in diabetic rats and its potential mechanism. Methods 30 rats were divided into normal control (NC), diabetes (DM) and liraglutide-treated DM (DM+L) group. Serum creatinine (Scr), BUN and 24 hUAlb were measured before and after treatment. Renal morphological changes were evaluated by HE and PAS staining. Protein expressions of GLP-1 receptor (GLP-1R), endothelial nitric oxide synthase (eNOS), and p-eNOS were detected by Western blot. The eNOS activity was determined by ELISA. Results Compared to NC group, DM group and DM+L group showed that Scr, BUN, 24 hUAlb excretion were significantly increased (P<0.05 or P<0.01) and that specimen of renal biopsy showed inflammatory cells infiltration, fibrosis and even glomerular sclerosis. There were no significant differences in eNOS expression between two groups, however the expression of GLP-1R, p-eNOS and eNOS activity were significantly decreased (P<0.05 or P<0.01). Compared with DM group, DM+L group showed that Scr, BUN and 24 hUAlb excretion were significantly decreased (P<0.05 or P<0.01), and that the expression of GLP-1R, p-eNOS and eNOS activity were significantly increased (P<0.05 or P<0.01). Conclusion Liraglutide could reduce urinary albumin excretion through up-regulating the expression of GLP-1R and then activating eNOS in kidney.

  【Key words】 Liraglutide;Diabetic nephropathy (DN);GLP-1 receptor (GLP-1R);Endothelial nitric oxide synthase (eNOS);Urinary albumin (UAlb) excretion

上一篇: 阿司匹林抗高糖诱导内皮细胞衰老过程中对一氧化氮-一氧化氮合酶系统的影响 下一篇:糖原性肝病肝穿刺病理诊断1例